Literature DB >> 25247435

The association between the ratio of monocytes: lymphocytes and risk of tuberculosis among HIV-infected postpartum women.

Vivek Naranbhai1, Dhayendre Moodley, Tsungai Chipato, Lynda Stranix-Chibanda, Clemensia Nakabaiito, Moreen Kamateeka, Philippa Musoke, Karim Manji, Kathleen George, Lynda M Emel, Paul Richardson, Philip Andrew, MaryGlenn Fowler, Helen Fletcher, Helen McShane, Hoosen M Coovadia, Adrian V S Hill.   

Abstract

Recent human studies support historical animal studies that suggested an association between peripheral blood monocyte:lymphocyte (ML) ratio and tuberculosis (TB) disease. To evaluate generalizability of this finding, we modeled the association between peripartum ML ratio and incident TB disease within 18 months postpartum among 1202 HIV-infected women in South Africa, Tanzania, Uganda, and Zimbabwe. The ML ratio was associated with increased risk of TB disease independently to combination antiretroviral therapy, World Health Organization stage, or CD4 count (adjusted hazard ratio = 1.22, 95% confidence interval: 1.07 to 1.4, P = 0.003 per 0.1 unit increase in ML ratio).

Entities:  

Mesh:

Year:  2014        PMID: 25247435      PMCID: PMC4229408          DOI: 10.1097/QAI.0000000000000353

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  10 in total

1.  The use of fractional polynomials to model continuous risk variables in epidemiology.

Authors:  P Royston; G Ambler; W Sauerbrei
Journal:  Int J Epidemiol       Date:  1999-10       Impact factor: 7.196

2.  Vertical transmission of Mycobacterium tuberculosis in KwaZulu Natal: impact of HIV-1 co-infection.

Authors:  T Pillay; A W Sturm; M Khan; M Adhikari; J Moodley; C Connolly; D Moodley; N Padayatchi; A Ramjee; H M Coovadia; J L Sullivan
Journal:  Int J Tuberc Lung Dis       Date:  2004-01       Impact factor: 2.373

3.  Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.

Authors:  Hoosen M Coovadia; Elizabeth R Brown; Mary Glenn Fowler; Tsungai Chipato; Dhayendre Moodley; Karim Manji; Philippa Musoke; Lynda Stranix-Chibanda; Vani Chetty; Wafaie Fawzi; Clemensia Nakabiito; Lindiwe Msweli; Roderick Kisenge; Laura Guay; Anthony Mwatha; Diana J Lynn; Susan H Eshleman; Paul Richardson; Kathleen George; Philip Andrew; Lynne M Mofenson; Sheryl Zwerski; Yvonne Maldonado
Journal:  Lancet       Date:  2011-12-22       Impact factor: 79.321

4.  Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.

Authors:  L A Guay; P Musoke; T Fleming; D Bagenda; M Allen; C Nakabiito; J Sherman; P Bakaki; C Ducar; M Deseyve; L Emel; M Mirochnick; M G Fowler; L Mofenson; P Miotti; K Dransfield; D Bray; F Mmiro; J B Jackson
Journal:  Lancet       Date:  1999-09-04       Impact factor: 79.321

Review 5.  Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps.

Authors:  Jyoti S Mathad; Amita Gupta
Journal:  Clin Infect Dis       Date:  2012-08-31       Impact factor: 9.079

6.  HIV disease progression in the first year after delivery among African women followed in the HPTN 046 clinical trial.

Authors:  D Heather Watts; Elizabeth R Brown; Yvonne Maldonado; Casey Herron; Tsungai Chipato; Leanne Reddy; Dhayendre Moodley; Clemensia Nakabiito; Karim Manji; Wafaie Fawzi; Kathleen George; Paul Richardson; Sheryl Zwerski; Hoosen Coovadia; Maryglenn Fowler
Journal:  J Acquir Immune Defic Syndr       Date:  2013-11-01       Impact factor: 3.731

Review 7.  Eliminating mother to child transmission of HIV-1 and keeping mothers alive: recent progress.

Authors:  Thiloshini Govender; Hoosen Coovadia
Journal:  J Infect       Date:  2013-10-16       Impact factor: 6.072

8.  Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial.

Authors:  Mary Glenn Fowler; Hoosen Coovadia; Casey M Herron; Yvonne Maldonado; Tsungai Chipato; Dhayendre Moodley; Philippa Musoke; Jim Aizire; Karim Manji; Lynda Stranix-Chibanda; Wafaie Fawzi; Vani Chetty; Lindiwe Msweli; Rodrick Kisenge; Elizabeth Brown; Anthony Mwatha; Susan H Eshleman; Paul Richardson; Melissa Allen; Kathleen George; Philip Andrew; Sheryl Zwerski; Lynne M Mofenson; J Brooks Jackson
Journal:  J Acquir Immune Defic Syndr       Date:  2014-03-01       Impact factor: 3.731

Review 9.  Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis.

Authors:  Molebogeng X Rangaka; Katalin A Wilkinson; Judith R Glynn; Daphne Ling; Dick Menzies; Judith Mwansa-Kambafwile; Katherine Fielding; Robert J Wilkinson; Madhukar Pai
Journal:  Lancet Infect Dis       Date:  2011-08-16       Impact factor: 25.071

10.  Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis among HIV-infected adults initiating antiretroviral therapy.

Authors:  Vivek Naranbhai; Adrian V S Hill; Salim S Abdool Karim; Kogieleum Naidoo; Quarraisha Abdool Karim; George M Warimwe; Helen McShane; Helen Fletcher
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

  10 in total
  14 in total

1.  Monocyte-to-Lymphocyte Ratio Is Associated With Tuberculosis Disease and Declines With Anti-TB Treatment in HIV-Infected Children.

Authors:  Rewa K Choudhary; Kristin M Wall; Irene Njuguna; Patricia B Pavlinac; Sylvia M LaCourse; Vincent Otieno; John Gatimu; Joshua Stern; Elizabeth Maleche-Obimbo; Dalton Wamalwa; Grace John-Stewart; Lisa M Cranmer
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

2.  Tuberculosis Case Finding in HIV-Infected Pregnant Women in Kenya Reveals Poor Performance of Symptom Screening and Rapid Diagnostic Tests.

Authors:  Sylvia M LaCourse; Lisa M Cranmer; Daniel Matemo; John Kinuthia; Barbra A Richardson; Grace John-Stewart; David J Horne
Journal:  J Acquir Immune Defic Syndr       Date:  2016-02-01       Impact factor: 3.731

3.  Quantitative IFN-γ and IL-2 Response Associated with Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women.

Authors:  Jyoti S Mathad; Ramesh Bhosale; Usha Balasubramanian; Savita Kanade; Vidya Mave; Nishi Suryavanshi; Nikhil Gupte; Samir Joshi; Ajay Chandanwale; Kathryn M Dupnik; Vandana Kulkarni; Prasad Deshpande; Daniel W Fitzgerald; Amita Gupta
Journal:  Am J Respir Crit Care Med       Date:  2016-06-15       Impact factor: 21.405

4.  Dietary Vitamin D3 Suppresses Pulmonary Immunopathology Associated with Late-Stage Tuberculosis in C3HeB/FeJ Mice.

Authors:  Allison E Reeme; Richard T Robinson
Journal:  J Immunol       Date:  2016-01-04       Impact factor: 5.426

Review 5.  The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010-2014.

Authors:  Michael J Brennan; Rachel Tanner; Sheldon Morris; Thomas J Scriba; Jacqueline M Achkar; Andrea Zelmer; David A Hokey; Angelo Izzo; Sally Sharpe; Ann Williams; Adam Penn-Nicholson; Mzwandile Erasmus; Elena Stylianou; Daniel F Hoft; Helen McShane; Helen A Fletcher
Journal:  Clin Vaccine Immunol       Date:  2017-09-05

Review 6.  What We Have Learned and What We Have Missed in Tuberculosis Pathophysiology for a New Vaccine Design: Searching for the "Pink Swan".

Authors:  Pere-Joan Cardona
Journal:  Front Immunol       Date:  2017-05-15       Impact factor: 7.561

7.  High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation.

Authors:  Laura Sibley; Andrew D White; Karen E Gooch; Lisa M Stevens; Rachel Tanner; Ashley Jacobs; Owen Daykin-Pont; Fergus Gleeson; Anthony McIntyre; Randall Basaraba; Simon Clark; Graham Hall; Geoff Pearson; Emma Rayner; Helen McShane; Ann Williams; Mike Dennis; Philip D Marsh; Sally Sharpe
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.996

Review 8.  TB vaccine development and the End TB Strategy: importance and current status.

Authors:  Helen A Fletcher; Lewis Schrager
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-04       Impact factor: 2.184

9.  Human newborn bacille Calmette-Guérin vaccination and risk of tuberculosis disease: a case-control study.

Authors:  Helen A Fletcher; Ali Filali-Mouhim; Elisa Nemes; Anthony Hawkridge; Alana Keyser; Samuel Njikan; Mark Hatherill; Thomas J Scriba; Brian Abel; Benjamin M Kagina; Ashley Veldsman; Nancy Marín Agudelo; Gilla Kaplan; Gregory D Hussey; Rafick-Pierre Sekaly; Willem A Hanekom
Journal:  BMC Med       Date:  2016-05-16       Impact factor: 8.775

10.  Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes.

Authors:  Vivek Naranbhai; Helen A Fletcher; Rachel Tanner; Matthew K O'Shea; Helen McShane; Benjamin P Fairfax; Julian C Knight; Adrian V S Hill
Journal:  EBioMedicine       Date:  2015-11       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.